Cardinal Health Inc. closed 4.35% short of its 52-week high of $132.84, which the company achieved on January 30th.

Wells Fargo analyst Stephen Baxter maintained Cardinal Health with an Equal-Weight and raised the price target from $135 to ...

Fintel reports that on February 5, 2025, Jefferies upgraded their outlook for Cardinal Health (NYSE:CAH) from Hold to Buy.

Paul Singer’s Elliott Investment Management disclosed in an SEC filing its holdings as of December 31, 2024. The fund exited two positions ...

Jefferies has upgraded Cardinal Health (CAH) to buy from hold, citing management's emerging EPS track record. Read more here.

Perigon Wealth Management LLC lifted its stake in shares of Cardinal Health, Inc. (NYSE:CAH – Free Report) by 13.0% during ...

There’s a lot to be optimistic about in the Healthcare sector as 2 analysts just weighed in on Cardinal Health (CAH – Research Report) and Apyx ...

Dublin, Ohio-based Cardinal Health, Inc. (CAH) manufactures and distributes pharmaceuticals, medical & laboratory products, ...

Cardinal Health reported an increase in revenue for two of its segments, while the departure of Optimum impacted its ...

Robust demand across its pharmaceutical and specialty solutions segment was the impetus behind Cardinal Health raising its fiscal 2025 enterprise guidance, said Jason Hollar, CEO of Cardinal ...

It was the Cardinal’s birthday. The thing is, what do you tell a Cardinal? I know it’s not mazel tov. And what do you give a Cardinal? Forget wardrobe, jeans or a puffer jacket. Can’t go ...